Latest News
Bonesupport shifts CERAMENT V review to FDA's De Novo pathway
2 December 2025 - Swedish orthobiologics company Bonesupport Holding AB (STO:BONEX) announced on Tuesday that it will move its US market application for CERAMENT V (vancomycin) for bone infection from the 510(k) route to the De Novo process.The compa...
Neola Medical secures US patent for disposable lung monitoring probes
2 December 2025 - Medical technology company Neola Medical AB (NASDAQ First North Growth Market:NEOLA) said on Tuesday that it has been granted a US patent for its disposable probes used with the Neola medical device.The advanced light and detector p...
Spinogenix reports approval of 'tazbentetol' as non-proprietary name for SPG302
2 December 2025 - Clinical-stage pharmaceutical company Spinogenix Inc announced on Monday that it has received approval from the International Nonproprietary Names (INN) Expert Committee of the World Health Organization for 'tazbentetol' a...
Mitsubishi Tanabe Pharma America changes name
2 December 2025 - Mitsubishi Tanabe Pharma America Inc (MTPA), a subsidiary of Japan-based Mitsubishi Tanabe Pharma Corporation (MTPC), announced on Monday that it has changed its corporate name to Tanabe Pharma America Inc (TPA), effective immediate...
Cosmo and Glenmark receive European marketing authorisation for Winlevi
2 December 2025 - Ireland-based life sciences company Cosmo Pharmaceuticals NV (SIX:COPN) and Glenmark Pharmaceuticals Limited (BSE:532296) (NSE:GLENMARK), an India-based pharmaceutical company, announced on Monday that they have received marketing a...